Back

Genomic analysis of SARS-CoV-2 breakthrough infections from Varanasi, India

Zaveri, L.; Singh, R.; Basu, P.; Banu, S.; Mukherjee, P.; Vishwakarma, S.; Sahni, C.; Kaur, M.; Singh, N. K.; Yadav, A. K.; Yadav, A. K.; Ashish, A.; Mishra, S.; Tiwari, S.; Mishra, S. P.; Vodapalli, A.; Bollu, H.; Das, D.; Singh, P. P.; Chaubey, G.; Sowpati, D. T.; Tallapaka, K. B.

2021-09-22 infectious diseases
10.1101/2021.09.19.21262487 medRxiv
Show abstract

Studies worldwide have shown that the available vaccines are highly effective against SARS-CoV-2. However, there are growing laboratory reports that the newer variants of concerns (VOCs e.g. Alpha, Beta, Delta etc) may evade vaccine induced defense. In addition to that, there are few ground reports on health workers having breakthrough infections. In order to understand VOC driven breakthrough infection we investigated 14 individuals who tested positive for SARS-CoV-2 after being administered a single or double dose of Covishield (ChAdOx1, Serum Institute of India) from the city of Varanasi, which is located in the Indian state of Uttar Pradesh. Genomic analysis revealed that 78.6% (11/14) of the patients were infected with the B.1.617.2 (Delta) variant. Notably, the frequency (37%) of this variant in the region was significantly lower (p<0.01), suggesting that the vaccinated people were asymmetrically infected with the Delta variant. Most of the patients tested displayed mild symptoms, indicating that even a single dose of the vaccine can help in reducing the severity of the disease. However, more comprehensive epidemiological studies are required to understand the effectiveness of vaccines against the newer VOCs.

Matching journals

The top 11 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.